These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 15276467)

  • 1. TGF-beta1 and angiotensin networking in cardiac remodeling.
    Rosenkranz S
    Cardiovasc Res; 2004 Aug; 63(3):423-32. PubMed ID: 15276467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts.
    Campbell SE; Katwa LC
    J Mol Cell Cardiol; 1997 Jul; 29(7):1947-58. PubMed ID: 9236148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.
    Tsuruda T; Kato J; Hatakeyama K; Masuyama H; Cao YN; Imamura T; Kitamura K; Asada Y; Eto T
    Cardiovasc Res; 2005 Mar; 65(4):921-9. PubMed ID: 15721873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.
    Gao X; He X; Luo B; Peng L; Lin J; Zuo Z
    Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts.
    Booz GW; Baker KM
    Cardiovasc Res; 1995 Oct; 30(4):537-43. PubMed ID: 8575002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GH suppresses TGF-beta-mediated fibrosis and retains cardiac diastolic function.
    Imanishi R; Ashizawa N; Ohtsuru A; Seto S; Akiyama-Uchida Y; Kawano H; Kuroda H; Nakashima M; Saenko VA; Yamashita S; Yano K
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):137-46. PubMed ID: 15130518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis.
    Chen CM; Chou HC; Hsu HH; Wang LF
    Toxicology; 2005 Dec; 216(2-3):181-7. PubMed ID: 16182431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans retinoic acid inhibited angiotensin II-induced increase in cell growth and collagen secretion of neonatal cardiac fibroblasts.
    He Y; Huang Y; Zhou L; Lu LM; Zhu YC; Yao T
    Acta Pharmacol Sin; 2006 Apr; 27(4):423-9. PubMed ID: 16539842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy.
    Baker KM; Chernin MI; Schreiber T; Sanghi S; Haiderzaidi S; Booz GW; Dostal DE; Kumar R
    Regul Pept; 2004 Aug; 120(1-3):5-13. PubMed ID: 15177915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks.
    Schlüter KD; Wenzel S
    Pharmacol Ther; 2008 Sep; 119(3):311-25. PubMed ID: 18619489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
    Chen J; Chen JK; Neilson EG; Harris RC
    J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells.
    Kim YM; Jeon ES; Kim MR; Jho SK; Ryu SW; Kim JH
    Int J Biochem Cell Biol; 2008; 40(11):2482-91. PubMed ID: 18571460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters (BIO14.6): involvement of transforming growth factor-beta 1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy].
    Sakata Y
    Hokkaido Igaku Zasshi; 1993 Jan; 68(1):18-28. PubMed ID: 8383086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
    Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
    J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C epsilon mediates angiotensin II-induced activation of beta1-integrins in cardiac fibroblasts.
    Stawowy P; Margeta C; Blaschke F; Lindschau C; Spencer-Hänsch C; Leitges M; Biagini G; Fleck E; Graf K
    Cardiovasc Res; 2005 Jul; 67(1):50-9. PubMed ID: 15949469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models.
    Xiao H; Zhang YY
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):335-41. PubMed ID: 18290874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.